Combo therapy shows potential for melanoma, ovarian cancer

02/19/2008 | Yahoo!

A combination of a CTLA-4-blocking antibody and a GVAX cancer vaccine may be more effective in treating melanoma and advanced ovarian cancer than either treatment on its own, according to a U.S. study. Researchers reported that none of the patients who received the combination therapy experienced severe adverse reactions, while some found that their tumors had shrunk or stabilized.

View Full Article in:


Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Attest Health Care Advisors
Nationwide, SL_Nationwide
NGS Provider Enrollment Rep
National Government Services - WellPoint
Harrisburg, PA
Program Manager II
Tufts Health Plan/Network Health
Medford, MA
Director, Medicare Advantage/Medicare Part D Focus
Avalere Health
Washington, DC
Director of Clinical Research
Regenesis Biomedical, Inc.
Scottsdale, AZ